Understanding how drugs work in children with leukemia
Official title: Pharmacokinetics of Drugs Administered to Children Per Standard of Care
Run by Duke University · NCT03481881 · Data updated 2026-11-12
This study looks at how well certain leukemia medications work in children under 21 to better understand their safety and effectiveness.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 20 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | August 14, 2013 |
| Main results expected | August 14, 2033 |
| Study ends | August 14, 2033 |
| Registry record updated | January 7, 2026 |
| Trial ID | NCT03481881 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children under 21 years of age who are receiving specific drugs for pediatric ALL as part of their standard treatment.
✕Probably not a fit
Patients who are not receiving the drugs of interest or those who cannot provide consent or assent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to characterize the pharmacokinetics (PK) of drugs administered to children under 21 years of age who are receiving treatment for pediatric acute lymphoblastic leukemia (ALL). The study will involve monitoring the standard of care drugs prescribed by the treating caregivers to gather data on how these medications are processed in the bodies of young patients. By focusing on understudied drugs, the research seeks to fill gaps in knowledge regarding their effectiveness and safety in this specific population.
Why it matters
Potential benefit: If successful, this study could lead to improved drug dosing and treatment strategies for children with leukemia, enhancing their overall care.
How similar studies have gone: While pharmacokinetics studies in pediatric populations are common, this specific focus on understudied drugs in pediatric ALL is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children (\< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver Exclusion Criteria: * Failure to obtain consent/assent (as indicated)
Where it's running
-
Duke University
Durham, North Carolina, United States Recruiting
Study contacts
- Study coordinator: Rachel G Greenberg, MD
- Email: rachel.greenberg@duke.edu
- Phone: 9196684725
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nature-based program feasibility in preschools near public housing
This feasibility study tests whether a nature-based program in preschools near public housing can be run smoothly and whether families will participate and benefit.
-
Comparing two ultrasound methods for femoral artery access in children
This trial tests whether a modified ultrasound technique helps anesthesia residents place femoral arterial lines faster and with fewer attempts in infants and children having heart surgery.
-
Optimizing therapy components for pediatric PTSD with a multiphase design
This project will try different therapy pieces to see which combinations help children and teens (ages 8–17) with PTSD feel better.
-
Registry of long-term outcomes for children after cardiac arrest
This study is looking at the long-term health and recovery of children in the Netherlands who have had a cardiac arrest to see how well they do after treatment.
-
Evaluating sedation effectiveness with dexmedetomidine in children undergoing brain MRI
This study is testing if a nasal spray of dexmedetomidine can safely and effectively help children aged 12 months to 18 years relax during a brain MRI.
-
Pediatric eCART: an electronic tool to spot children at high risk of critical illness
This project will test whether implementing pediatric eCART, an EHR-based risk alert system, helps identify hospitalized children at high risk of life-threatening deterioration and is acceptable to pediatric nurses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.